Log In
Print this Print this

Lialda, Mezavant, Mezavant XL, mesalamine (MMX Mesalazine) (GED 0001, MD-0901, SPD476)

Also known as: formerly Mesavance

  Manage Alerts
Collapse Summary General Information
Company Nogra Pharma Ltd.
Description5-aminosalicylate (5-ASA) mesalamine formulated using Multi-Matrix system (MMX) technology
Molecular Target Cyclooxygenases (COX)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today